What HoLEP actually removes, and why the prostate findings decide the conversation
HoLEP stands for holmium laser enucleation of the prostate. In plain terms, the surgeon uses a laser to remove obstructing prostate tissue through the urethra, so there is no abdominal incision. The removed tissue is not discarded automatically: it can be sent for pathological examination. That single fact explains why your existing prostate findings are central to the assessment rather than background paperwork.
The assessment question is not simply whether you have an enlarged prostate. It is whether the pattern of obstruction shown by your tests matches what HoLEP is designed to treat, and whether anything in the findings suggests a different problem that needs a different pathway. A raised prostate-specific antigen (PSA), an abnormal digital rectal examination, or a suspicious lesion on imaging can point toward cancer assessment rather than benign obstruction. HoLEP is not radical prostatectomy, which is cancer surgery with a different purpose, different risks and different follow-up. If your records contain a cancer diagnosis or an unresolved suspicion of cancer, say so plainly at the start, because it changes which specialist should review you.
This is also why a general enquiry cannot answer the suitability question. The hospital needs the actual images, reports and values, not a summary that says the prostate is enlarged. A coordinator can help organise and translate records, but the clinical judgement belongs to the treating urologist.
Which prostate and urinary findings the treating team will want to see
The exact test list is a clinical decision, so treat the following as the categories to discuss with the receiving team rather than a mandatory checklist. The point is to arrive with the source documents, not a verbal recollection.
Prostate imaging and volume assessment: ultrasound or MRI reports describing prostate size, shape and any suspicious area. Prostate volume influences technique and planning, and the report should include measurements rather than only a conclusion.
Urinary flow and residual urine: uroflowmetry and post-void residual measurements show how much obstruction is present and how well the bladder empties. These are often the findings that make the case for or against an obstructive procedure.
Blood tests: PSA with its date and reference range, plus kidney function, because longstanding obstruction can affect the upper urinary tract.
Symptom scores and medication history: a completed symptom questionnaire and a list of current medicines, including alpha-blockers, 5-alpha-reductase inhibitors and any anticoagulant or antiplatelet drug. Do not stop or change any medicine on your own; the treating team must advise on this.
Previous urological procedures, catheter history, urinary infections, stones or bladder findings, and any biopsy or pathology report already performed.
Why a missing finding changes the decision, not just the paperwork
A gap in the record is not a formality. If the PSA result is missing, the team cannot weigh the cancer question properly. If the residual urine measurement is old or absent, the degree of obstruction is unclear. If the imaging report describes a suspicious area without images, the reviewer may need the actual study or a repeat view.
There is a practical consequence for travel planning. A records-based opinion can clarify whether HoLEP is a plausible route, but it does not establish hospital acceptance, a surgery date or fitness to travel. Those are separate steps that follow the hospital's own review. Building a trip around an unconfirmed plan creates avoidable risk, especially if further tests are requested on arrival.
It also matters for the pathology question. Because tissue removed during HoLEP can be examined, the treating team should explain in advance how results will be communicated, who will discuss them with you, and what happens if the examination shows something unexpected. Ask this before the procedure, not afterwards. The answer is specific to the hospital and the individual case.
Questions that turn your findings into a clear plan
Bring a short written list. Vague questions produce vague answers, and a second opinion is only useful if it addresses the decision you actually face.
Ask whether the pattern of findings supports an obstructive procedure at all, and what alternatives exist, including continued medical management or other surgical options. Ask how the team interprets your prostate volume and residual urine in your specific case. Ask whether any finding needs further assessment before a procedure is considered, and what that assessment involves.
Ask what the proposed follow-up looks like after HoLEP: who removes or manages the catheter, what symptoms should prompt urgent contact, when a review appointment is expected, and how pathology results will be delivered. Ask whether you will need to remain locally for a period after the procedure, and what the team advises about flying. Do not rely on a general timeline from any website, including this one; the treating team sets these instructions for your case.
Ask what the written estimate covers and what it excludes, and whether ward type affects it. Ask how interpretation will be arranged for consent discussions and follow-up, and confirm that important conversations happen before any sedation.
Preparing records for a China-based review without over-sharing
Start with a brief summary: your main urinary problem, when it began, what has been tried, and your single most important question. You do not need to send a complete medical archive at first contact, and you should not send passport numbers or payment details through an article enquiry.
Once a review route is agreed, share the relevant reports in an organised way: imaging reports and images if available, flow and residual results, PSA and kidney function with dates, medication list, and any prior pathology. Keep original files and provide clear scans or PDFs rather than photographs of screens. If a report is in another language, a translation helps, but the original document should accompany it.
Be explicit about anything that could change the pathway: a known or suspected cancer diagnosis, previous prostate surgery, bleeding disorders, anticoagulant use, recurrent urinary infections, or a catheter currently in place. These are not reasons for embarrassment; they are the details that determine whether a remote review is meaningful or whether you need local assessment first.
The limits of an overseas enquiry, and a sensible next step
An enquiry is a way to find out whether a records-based review is worthwhile and what information is missing. It is not a diagnosis, not a treatment plan, and not a promise of acceptance. If you have severe pain, inability to pass urine, fever with urinary symptoms, or rapidly worsening kidney function, seek local urgent care rather than waiting for an overseas reply.
If your situation is stable and you are considering HoLEP in China, the practical next step is to send a short summary through the enquiry form, email or WhatsApp. The team checks the available diagnosis, records and your main question, identifies missing information and suggests the relevant next step. This initial review is free, and a proxy consultation is optional rather than a prerequisite. The hospital decides suitability after reviewing your actual findings.
For confirmed services, ChinaSpecialistCare coordinates specialist matching, appointment registration and hospital or surgery arrangements after acceptance, with interpretation and practical support available separately. Clinical decisions, including whether HoLEP is appropriate and what follow-up you need, remain with the treating hospital and licensed clinicians.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.